241 related articles for article (PubMed ID: 28195105)
1. Hereditary leiomyomatosis and renal cell cancer syndrome associated renal cell carcinoma.
Adamane S; Desai S; Menon S
Indian J Pathol Microbiol; 2017; 60(1):108-110. PubMed ID: 28195105
[TBL] [Abstract][Full Text] [Related]
2. The syndrome of hereditary leiomyomatosis and renal cell cancer (HLRCC): The clinical features of an individual with a fumarate hydratase gene mutation.
Varol A; Stapleton K; Roscioli T
Australas J Dermatol; 2006 Nov; 47(4):274-6. PubMed ID: 17034471
[TBL] [Abstract][Full Text] [Related]
3. Morphology and Immunohistochemistry for 2SC and FH Aid in Detection of Fumarate Hydratase Gene Aberrations in Uterine Leiomyomas From Young Patients.
Joseph NM; Solomon DA; Frizzell N; Rabban JT; Zaloudek C; Garg K
Am J Surg Pathol; 2015 Nov; 39(11):1529-39. PubMed ID: 26457356
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemistry for 2-Succinocysteine (2SC) and Fumarate Hydratase (FH) in Cutaneous Leiomyomas May Aid in Identification of Patients With HLRCC (Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome).
Buelow B; Cohen J; Nagymanyoki Z; Frizzell N; Joseph NM; McCalmont T; Garg K
Am J Surg Pathol; 2016 Jul; 40(7):982-8. PubMed ID: 26945337
[TBL] [Abstract][Full Text] [Related]
5. Fumarate Hydratase-deficient Renal Cell Carcinoma Is Strongly Correlated With Fumarate Hydratase Mutation and Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome.
Trpkov K; Hes O; Agaimy A; Bonert M; Martinek P; Magi-Galluzzi C; Kristiansen G; Lüders C; Nesi G; Compérat E; Sibony M; Berney DM; Mehra R; Brimo F; Hartmann A; Husain A; Frizzell N; Hills K; Maclean F; Srinivasan B; Gill AJ
Am J Surg Pathol; 2016 Jul; 40(7):865-75. PubMed ID: 26900816
[TBL] [Abstract][Full Text] [Related]
6. Hereditary leiomyomatosis and renal cell carcinoma syndrome-associated renal cell carcinoma: Morphological appraisal with a comprehensive review of differential diagnoses.
El-Zaatari Z; Divatia MK
Indian J Pathol Microbiol; 2020 Feb; 63(Supplement):S7-S17. PubMed ID: 32108620
[TBL] [Abstract][Full Text] [Related]
7. Hereditary Leiomyomatosis and Renal Cell Cancer: Clinical, Molecular, and Screening Features in a Cohort of 185 Affected Individuals.
Forde C; Lim DHK; Alwan Y; Burghel G; Butland L; Cleaver R; Dixit A; Evans DG; Hanson H; Lalloo F; Oliveira P; Vialard L; Wallis Y; Maher ER; Woodward ER
Eur Urol Oncol; 2020 Dec; 3(6):764-772. PubMed ID: 31831373
[TBL] [Abstract][Full Text] [Related]
8. Complexities in estimating the true risk of hereditary leiomyomatosis and renal cell carcinoma and the development of kidney cancer.
Ball MW; Ricketts CJ
Cancer; 2020 Aug; 126(16):3617-3619. PubMed ID: 32413160
[No Abstract] [Full Text] [Related]
9. Atypical presentation of Reed syndrome.
Fernández Canga P; Castiñeiras González J; Sánchez Sambucety P
Med Clin (Barc); 2019 Jun; 152(11):468-469. PubMed ID: 30470440
[No Abstract] [Full Text] [Related]
10. Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC): Report of a Family Pedigree.
Choi G; Kimonis V; Hall K; Lau WL
Am J Med Sci; 2020 Dec; 360(6):724-727. PubMed ID: 32703534
[TBL] [Abstract][Full Text] [Related]
11. Loss of Fumarate Hydratase and Aberrant Protein Succination Detected With S-(2-Succino)-Cysteine Staining to Identify Patients With Multiple Cutaneous and Uterine Leiomyomatosis and Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome.
Llamas-Velasco M; Requena L; Adam J; Frizzell N; Hartmann A; Mentzel T
Am J Dermatopathol; 2016 Dec; 38(12):887-891. PubMed ID: 27097334
[TBL] [Abstract][Full Text] [Related]
12. Expanding morphological and clinical aspects of hereditary leiomyomatosis and renal cell carcinoma (HLRCC): a case report in a patient with unusual morphology and clinical presentation.
da Cunha IW; da Costa WH; Morini MA; Bezerra SM; Carraro DM; Torrezan GT; Formiga MNC; Guimaraes GC; Zequi SC; Soares FA
Virchows Arch; 2018 Dec; 473(6):775-779. PubMed ID: 30171332
[TBL] [Abstract][Full Text] [Related]
13. Reassessing the clinical spectrum associated with hereditary leiomyomatosis and renal cell carcinoma syndrome in French FH mutation carriers.
Muller M; Ferlicot S; Guillaud-Bataille M; Le Teuff G; Genestie C; Deveaux S; Slama A; Poulalhon N; Escudier B; Albiges L; Soufir N; Avril MF; Gardie B; Saldana C; Allory Y; Gimenez-Roqueplo AP; Bressac-de Paillerets B; Richard S; Benusiglio PR
Clin Genet; 2017 Dec; 92(6):606-615. PubMed ID: 28300276
[TBL] [Abstract][Full Text] [Related]
14. Novel missense mutation in the FH gene in familial renal cell cancer patients lacking cutaneous leiomyomas.
Kuwada M; Chihara Y; Lou Y; Torimoto K; Kagebayashi Y; Tamura K; Shuin T; Fujimoto K; Kuniyasu H; Samma S
BMC Res Notes; 2014 Mar; 7():203. PubMed ID: 24684806
[TBL] [Abstract][Full Text] [Related]
15. Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome (HLRCC): A Contemporary Review and Practical Discussion of the Differential Diagnosis for HLRCC-Associated Renal Cell Carcinoma.
Skala SL; Dhanasekaran SM; Mehra R
Arch Pathol Lab Med; 2018 Oct; 142(10):1202-1215. PubMed ID: 30281371
[TBL] [Abstract][Full Text] [Related]
16. Multiple cutaneous and uterine leiomyomatosis in a 36-year-old female, and discussion of hereditary leiomyomatosis and renal cell carcinoma.
Henley ND; Tokarz VA
Int J Dermatol; 2012 Oct; 51(10):1213-6. PubMed ID: 22994667
[No Abstract] [Full Text] [Related]
17. Hereditary leiomyomatosis and renal cell carcinoma/fumarate hydratase-deficient renal cell carcinoma: two primaries in one.
Storey B; Shugg N; Grant A
ANZ J Surg; 2020 Apr; 90(4):E93-E94. PubMed ID: 31271241
[No Abstract] [Full Text] [Related]
18. Detailed Morphologic and Immunohistochemical Characterization of Myomectomy and Hysterectomy Specimens From Women With Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome (HLRCC).
Chan E; Rabban JT; Mak J; Zaloudek C; Garg K
Am J Surg Pathol; 2019 Sep; 43(9):1170-1179. PubMed ID: 31162287
[TBL] [Abstract][Full Text] [Related]
19. Utility of prospective pathologic evaluation to inform clinical genetic testing for hereditary leiomyomatosis and renal cell carcinoma.
Kopp RP; Stratton KL; Glogowski E; Schrader KA; Rau-Murthy R; Russo P; Coleman JA; Offit K
Cancer; 2017 Jul; 123(13):2452-2458. PubMed ID: 28171700
[TBL] [Abstract][Full Text] [Related]
20. Radical nephrectomy and regional lymph node dissection for locally advanced type 2 papillary renal cell carcinoma in an at-risk individual from a family with hereditary leiomyomatosis and renal cell cancer: a case report.
Kamai T; Abe H; Arai K; Murakami S; Sakamoto S; Kaji Y; Yoshida KI
BMC Cancer; 2016 Mar; 16():232. PubMed ID: 26983443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
